Table 2 Baseline and clinicopathological characteristics of UTUC patients

Sex

0.769

 Female

137 (50.4%)

110 (52.1%)

 Male

135 (49.6%)

101 (47.9%)

Age

 < 0.001

  < 65

59 (21.7%)

91 (43.1%)

  ≥ 65

213 (78.3%)

120 (56.9%)

BMI

0.253

  < 25

155 (57.0%)

132 (62.6%)

  ≥ 25

117 (43.0%)

79 (37.4%)

Side

0.211

 Left

161 (59.2%)

112 (53.1%)

 Right

111 (40.8%)

99 (46.9%)

Site

0.001

 Both

24 (8.82%)

7 (3.32%)

 Pelvis

99 (36.4%)

107 (50.7%)

 Ureter

149 (54.8%)

97 (46.0%)

Approach

 < 0.001

 Laparoscopic

132 (48.5%)

150 (71.1%)

 Open

140 (51.5%)

61 (28.9%)

Ureteroscopy

0.085

 No

227 (83.5%)

162 (76.8%)

 Yes

45 (16.5%)

49 (23.2%)

Hematuresis

0.904

 No

71 (26.1%)

57 (27.0%)

 Yes

201 (73.9%)

154 (73.0%)

Urine pathology

0.015

 No

62 (22.8%)

70 (33.2%)

 Yes

210 (77.2%)

141 (66.8%)

Hydronephrosis

 < 0.001

 No

43 (15.8%)

67 (31.8%)

 Yes

229 (84.2%)

144 (68.2%)

Multifocality

0.064

 No

228 (83.8%)

190 (90.0%)

 Yes

44 (16.2%)

21 (9.95%)

Size

0.020

  < 5

225 (82.7%)

191 (90.5%)

  ≥ 5

47 (17.3%)

20 (9.48%)

LVI

0.288

 No

228 (83.8%)

185 (87.7%)

 Yes

44 (16.2%)

26 (12.3%)

Tis

0.505

 No

257 (94.5%)

203 (96.2%)

 Yes

15 (5.51%)

8 (3.79%)

T stage

0.002

 T1

59 (21.7%)

69 (32.7%)

 T2

86 (31.6%)

57 (27.0%)

 T3

108 (39.7%)

82 (38.9%)

 T4

19 (6.99%)

3 (1.42%)

Margin

0.072

 Negative

261 (96.0%)

209 (99.1%)

 Positive

11 (4.04%)

2 (0.95%)

pN + 

0.012

 N0&Nx

246 (90.4%)

204 (96.7%)

 N + 

26 (9.56%)

7 (3.32%)

Chemotherapy

0.987

 No

223 (82%)

174 (82,5%)

 Yes

49 (18%)

37 (17.5%)

Grade

1.000

 High

219 (80.5%)

170 (80.6%)

 Low

53 (19.5%)

41 (19.4%)